Antimicrobials News

Rates of STDs continue to rise in the United States, with CDC data showing increases year after year.

The front page of Healio | Infectious Disease News this year included stories about COVID-19, new vaccines, reversing decades of ID dogma, and more.

To mark the end of 2023, we compiled a list of this year’s Pharmacology Consult columns, in which our contributing PharmDs dig deep into the newest research to report on emerging therapies and vaccines for infectious diseases.

CDC data show a spike in infective endocarditis deaths among young adults despite an overall decline in such deaths from 1999 to 2020, with researchers citing the role of comorbid opioid use disorder.

For the past 5 years, we have asked infectious disease clinicians to tell us when and why they chose a career in ID.

Researchers determined that first-year college students living on campus and/or affiliated with campus Greek life have an increased risk for meningococcal disease.

In the United States, there were approximately 1.6 million cases of chlamydia, 710,000 cases of gonorrhea and 176,000 cases of syphilis reported in 2021, according to the CDC.

Hospital-associated infections declined significantly at acute-care hospitals in 2022, although rates at other health care facilities remained relatively stagnant, according to a CDC report.

Few adverse events following outpatient parenteral antimicrobial therapy containing cefazolin and ceftriaxone were identified using routine laboratory monitoring, leading researchers to say the practice may be “excessive.”

The FDA designated a drug-device combination for periprosthetic joint infection in hip and knee replacement patients as a breakthrough therapy, which may accelerate its approval, the manufacturer said.